Media Center

Recent News

02/12/19ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results on February 26, 2019Printer Friendly Version
12/20/18ACADIA Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference on January 9, 2019Printer Friendly Version
11/30/18ACADIA Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesPrinter Friendly Version
11/27/18ACADIA Pharmaceuticals Prices Public Offering of Common StockPrinter Friendly Version
11/26/18ACADIA Pharmaceuticals Announces Proposed Public Offering of Common StockPrinter Friendly Version
2019 | 2018 | 2017 | Archive

Company Information

Annual Report


Scientific Publications

Pimavanserin for patients with Parkinson's disease psychosis: a randomized, placebo-controlled phase 3 trial. The Lancet, 383, 533-540 (2014).